Andrew James Buniack’s Post

View profile for Andrew James Buniack, graphic

Program Analyst (VERA) Veterans Equitable Resource Allocation US Army (SFC Retired)

Eight in 10 (81.4 percent) supported patient consent for AI model use during treatment decisions. In a scenario in which an AI decision model selected a different treatment regimen than the oncologist planned to recommend, most respondents said they would present both options and let the patient decide (36.8 percent), with those from academic settings more likely than those from other settings to let the patient decide (odds ratio, 2.56). Three-quarters of respondents (76.5 percent) agreed that oncologists should protect patients from biased AI tools, but only 27.9 percent were confident in their ability to identify poorly representative AI models.

Ethical Issues Abound in Adoption of Artificial Intelligence in Cancer Care

Ethical Issues Abound in Adoption of Artificial Intelligence in Cancer Care

healthday.com

To view or add a comment, sign in

Explore topics